US6756497B1 - Benzoic acid derivatives and processes for the preparation thereof - Google Patents

Benzoic acid derivatives and processes for the preparation thereof Download PDF

Info

Publication number
US6756497B1
US6756497B1 US09/720,825 US72082501A US6756497B1 US 6756497 B1 US6756497 B1 US 6756497B1 US 72082501 A US72082501 A US 72082501A US 6756497 B1 US6756497 B1 US 6756497B1
Authority
US
United States
Prior art keywords
group
formula
preparation
methyl
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
US09/720,825
Inventor
Yuuki Nakagawa
Masao Yamaguchi
Hiroyuki Adachi
Hiroyuki Yamanaka
Tomio Yagihara
Masami Hatano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Soda Co Ltd
Original Assignee
Nippon Soda Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Soda Co Ltd filed Critical Nippon Soda Co Ltd
Assigned to NIPPON SODA CO., LTD. reassignment NIPPON SODA CO., LTD. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: HATANO, MASAMI, YAGIHARA, TOMIO, NAKAGAWA, YUUKI, YAMAGUCHI, MASAO, YAMANAKA, HIROYUKI, ADACHI, HIROYUKI
Application granted granted Critical
Publication of US6756497B1 publication Critical patent/US6756497B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/04—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings

Definitions

  • the present invention relates to benzoic acid derivatives useful as intermediates for the preparation of drugs and agricultural chemicals, particularly compounds having herbicidal activity, and to processes for the preparation thereof.
  • Known methods of dehalogenation of aromatic halogenated compounds include, for example, catalytic hydrogenolysis using palladium-carbon or Raney nickel as a catalyst, a method of using metal and metal salts such as lithium or sodium, hydrogenolytic reduction with tin hydride, reduction with metal-hydrogen complex compounds such as lithium aluminum hydride, and electrolytic reduction, which are described in Shin Jikkenkagakukouza, Vol. 14, Syntheses and Reactions of Organic Compounds [I] pages 22-30 (edited by the Chemical Society of Japan, published by Maruzen Co., Ltd.).
  • Substituted benzoic acid compounds such as 4-alkylthiobenzoic acid derivatives, are important as intermediates for the preparation of agricultural chemicals and drugs. It has been desired to develop easy and industrially advantageous processes for the preparation of the said benzoic acid derivatives.
  • the present invention is directed to
  • R 1 is hydrogen or C 1-4 alkyl
  • R 2 is hydrogen or C 1-6 alkyl
  • Q is an optionally substituted, saturated or unsaturated, 5- or 6-membered heterocyclic group containing 1 to 4 N, O or S atoms and combining with the benzene ring via a carbon atom);
  • R 1 are as defined above, and X is chlorine or C 1-4 alkoxy and two X's may join to form a C 2-3 alkylenedioxy group optionally substituted with C 1-4 alkyl), and of acting a base and water or alcohol on a bicycloheptenone derivative of the said Formula (2) in an appropriate solvent;
  • R 1 , R 2 and Q are as defined above and R 4 is C 1-6 alkyl
  • R 4 is C 1-6 alkyl
  • R 1 is hydrogen, or C 1-4 alkyl such as methyl, ethyl, propyl, isopropyl n-butyl isobutyl s-butyl or t-butyl;
  • a R 2 is hydrogen, or C 1-6 alkyl such as methyl, ethyl, propyl, isopropyl, n-butyl, isobutyl, s-butyl t-butyl, n-pentyl, isopentyl, neopentyl, n-hexyl or isohexyl;
  • X is halogen such as chlorine, or C 1-4 alkoxy such as methoxy, ethoxy, propoxy, isopropoxy or butoxy;
  • Two X's may join to form a C 2-3 alkylenedioxy group, such as ethylenedioxy or trimethylenedioxy;
  • the said C 2-3 alkylenedioxy group may be substituted with C 1-4 alkyl such as methyl, ethyl, propyl, isopropyl, n-butyl, isobutyl, s-butyl and t-butyl; and
  • Q is an optionally substituted, saturated or unsaturate 5- or 6-membered heterocyclic group containing 1 to 4 N, O or S atoms and combining with the benzene or bicycloheptane ring via a carbon atom.
  • hetero rings include, for example, 5-membered heterocyclic groups containing 1 to 4 N, O or S atoms, such as
  • These groups may have one or more, same or different, substituents at arbitrary positions of the hetero rings.
  • substituents include, for example, C 1-4 alkyl such as methyl, ethyl, propyl isopropyl, n-butyl, isobutyl, s-butyl and t-butyl, and C 1-4 haloalkyl such as chloromethyl, dichloromethyl, trichloromethyl, fluoromethyl, difluoromethyl, trifluoromethyl, 1-fluoroethyl, 1,1-difluoroethyl, 2,2,2-trifluoroethyl and pentafluoroethyl.
  • Q is more preferably one of the following groups represented by Q-1 to Q-9.
  • R 3 is, for example, C 1-4 alkyl such as methyl, ethyl, propyl, isopropyl, n-butyl, isobutyl, s-butyl or t-butyl, or C 1-4 haloalkyl such as chloromethyl, dichloromethyl, trichloromethyl, fluoromethyl, difluoromethyl, trifluoromethyl, 1-fluoroethyl, 1,1-difluoroethyl, 2,2,2-trifluoroethyl or pentafluoroethyl, and n is 0 or an integer of 1 or 2.
  • C 1-4 alkyl such as methyl, ethyl, propyl, isopropyl, n-butyl, isobutyl, s-butyl or t-butyl
  • C 1-4 haloalkyl such as chloromethyl, dichloromethyl, trichloromethyl, fluoromethyl, di
  • R 4 is C 1-6 alkyl such as methyl, ethyl, propyl, isopropyl, n-butyl, isobutyl s-butyl, t-butyl, n-pentyl, isopentyl, neopentyl, n-hexyl or isohexyl.
  • the compounds of the present invention represented by the said Formulae (2) and (3), may have stereoisomers, depending on substituents at positions 5 and 6. They are all covered by the present invention.
  • the compounds of the present invention may be produced by the following processes:
  • a bicycloheptenone derivative (2) of Formula (2) is reacted with a base and water or alcohol in an appropriate solvent to give a compound of Formula (1).
  • Bases used for this reaction include, for example, alkali metal alcolates such as sodium methylate, sodium ethylate and potassium t-butoxide; alkali metal hydroxides such as sodium hydroxide and potassium hydroxide; alkaline earth metal hydroxides such as calcium hydroxide; alkali metal carbonates such as sodium carbonate, potassium carbonate and sodium hydrogen carbonate; and alkaline earth metal carbonates.
  • alkali metal alcolates such as sodium methylate, sodium ethylate and potassium t-butoxide
  • alkali metal hydroxides such as sodium hydroxide and potassium hydroxide
  • alkaline earth metal hydroxides such as calcium hydroxide
  • alkali metal carbonates such as sodium carbonate, potassium carbonate and sodium hydrogen carbonate
  • alkaline earth metal carbonates alkaline earth metal carbonates.
  • An amount of a base used is preferably 2 to 5 equivalents to 1 mole of a bicycloheptenone derivative (2).
  • Solvents able to be used for the reaction include alcohols such as methanol, ethanol, propanol, isopropanol, butanol and t-butanol; ethers such as diethyl ether and tetrahydrofuran (THF); hydrocarbons such as benzene and toluene; acetonitrile, dimethylformamide (DMF), water, toluene, benzene and the like, or mixtures of 2 or more of these solvents.
  • alcohols such as methanol, ethanol, propanol, isopropanol, butanol and t-butanol
  • ethers such as diethyl ether and tetrahydrofuran (THF)
  • hydrocarbons such as benzene and toluene
  • acetonitrile, dimethylformamide (DMF) water, toluene, benzene and the like, or mixtures of 2 or more of these solvent
  • alcoholic solvents that is, alcohols, or mixed solvents of alcohol and other solvents such as water and alcohol or alcohol and ether.
  • an ester (COOR 2 ) having a portion corresponding to an alcohol (R 2 OH) used or the alkoxide portion of a metal alkoxide (MOR 2 ) used can be obtained; for example, a methyl ester is obtained with the use of methyl alcohol and an ethyl ester from ethyl alcohol.
  • More preferred combinations of a base and a solvent include, for example, sodium methoxide and methanol (or a mixed solvent of methanol and other solvents), sodium ethoxide and ethanol (or a mixed solvent of ethanol and other solvents), sodium hydroxide and alcohol (or a mixed solvent of alcohol and other solvents), potassium hydroxide and alcohol (or a mixed solvent of alcohol and other solvents), and potassium t-butoxide and butanol.
  • Solvents used together with water are favorably alcohols and ethers.
  • bases the aforementioned hydroxides or carbonates are preferably used.
  • Preferred reaction temperatures are between ⁇ 10° C. and the boiling point of solvents used.
  • a bicycloheptenone derivative (2) can be obtained by hydrolysis of a bicycloheptene derivative (3) with an acid such as hydrochloric acid or sulfuric acid.
  • a compound (2) can be obtained by hydrolyzing a compound (3) without using a solvent or with a solvent including alcohols such as methanol, ethanol and t-butanol, ethers such as diethyl ether and tetrahydrofuran (THF) or aromatic hydrocarbons such as benzene and toluene, or a mixed solvent of two or more of these solvents, at temperature between ⁇ 10° C. and the boiling point of solvents used.
  • a solvent including alcohols such as methanol, ethanol and t-butanol, ethers such as diethyl ether and tetrahydrofuran (THF) or aromatic hydrocarbons such as benzene and toluene, or a mixed solvent of two or more of these solvents, at temperature between ⁇ 10° C. and the boiling point of solvents used.
  • a target benzoic acid derivative can be prepared in the same way as that described in Process 1 above.
  • the Diels-Alder reaction can be carried out according to methods described, for example, in Tetrahedron, 42, 1741-1744 (1986) or J. Org. Chem., 26, 2066-2072 (1961).
  • cyclopentadienes and ethylene derivatives are reacted while heating.
  • a molar ratio of the ethylene derivatives used in the reaction is 0.5 to 10 times in equivalent, preferably 1 to 3 equivalents, to 1 mole of cyclopentadienes.
  • the reaction is carried out at temperature between room temperature and 25° C., more preferably between 70° C. and 200° C.
  • solvents may be used.
  • solvents used include aromatic hydrocarbons such as benzene, toluene, xylene, chlorobenzene and dichlorobenzene; alcohols such as ethanol, n-propyl alcohol, ethylene glycol, 1,3-butanediol and ethylene glycol monomethyl ether; ethers such as dimethoxyethane, dioxane and diethylene glycol dimethyl ether, amides such as N,N-dimethylformamide, N,N-dimethylacetamide, N-methylpyrolidone and N,N-dimethylimidazoline; hydrocarbons containing sulfur such as dimethylsulfoxide and sulfolane, and water.
  • the reaction proceeds more smoothly by adding a polymerization inhibitor such as hydroquinone in the presence of a base such as sodium hydrogen carbonate, potassium hydrogen carbonate, sodium carbonate or potassium carbonate.
  • a polymerization inhibitor such as hydroquinone
  • a base such as sodium hydrogen carbonate, potassium hydrogen carbonate, sodium carbonate or potassium carbonate.
  • a compound of Formula (5) a starting material, can be prepared according to methods described, for example, in the following papers:
  • a 4,5-dichlorobenzoic acid derivative of Formula (1) is reacted with an excessive amount of alkane thiol of Formula R 4 SH (R 4 is as defined above) in an appropriate inert solvent in the presence of a base, to give a 4-alkylthiobenzoic acid derivative of Formula (6).
  • the reaction proceeds more smoothly under the irradiation of light (of a specified wavelength).
  • Various light sources can be used, including sunlight, fluorescent lights, mercury lamps, arc lamps and incandescent lamps. It is preferable to carry out the reaction under inert gas atmosphere, after the reaction system is sufficiently degassed.
  • the reaction may sometimes proceed more smoothly by adding water of 0.1 to 5 times in equivalent to the amount of 4,5-dichlorobenzoic acid derivative (1).
  • solvents used for this reaction are amides, such as dimethylformamide DMF), N,N-dimethylacetamide and N-methylpyrolidone.
  • amides such as dimethylformamide DMF
  • N,N-dimethylacetamide and N-methylpyrolidone.
  • solvents used are not restricted to them.
  • bases used include hydroxides such as sodium hydroxide and potassium hydroxide; carbonates such as sodium carbonate, sodium hydrogen carbonate, potassium carbonate and potassium hydrogen carbonate; and metal alcolates such as sodium methylate, sodium etheylate and potassium t-butoxide.
  • a salt of alkane thiol such as sodium or potassium salt of alkane thiol, prepared from an alkane thiol and a base beforehand, can be used for the reaction.
  • Amounts of base and alkane thiol used are preferably 2 to 20 equivalents to that of 4,5-dichlorobenzoic acid derivative (1).
  • Benzoic acid derivatives of Formula (6) can be produced by isolation of Compound (7) followed by reduction, as shown in the following reaction scheme:
  • the same alkane thiol (R 4 SH) as that used in the previous reaction can be used as a reducing agent.
  • other reducing agents such as hydrogen sulfide and aromatic thiols can be employed.
  • a compound of Formula (6) can be derived to a corresponding SO 2 R 4 compound (8) by oxidation reaction of the SR 4 group.
  • This oxidation reaction may be carried out using an oxidizing agent including peroxides such as hydrogen peroxide, peracetic acid, perbenzoic acid and m-chloroperbenzoic acid, and hypochlorites such as sodium hypochlorite and potassium hypochlorite, in an inert solvent including water, alcohols such as methanol and ethanol organic acids such as acetic acid, and halogenated hydrocarbons such as dichloromethane, chloroform and carbon tetrachloride.
  • the reaction proceeds smoothly in the temperature range from 0° C. to the boiling point of the solvent used.
  • a SO 2 R 4 compound (8) can be obtained by oxidation of a compound of the said Formula (7) and then a reduction reaction for dechlorination.
  • a compound of Formula (9) can be produced by oxidation of a compound of Formula (7).
  • This oxidation reaction may be carried out using an oxidizing agent including peroxides such as hydrogen peroxide, peracetic acid, perbenzoic acid and m-chloroperbenzoic acid, and hypochlorites such as sodium hypochlorite and potassium hypochlorite, in an inert solvent including water, alcohols such as methanol and ethanol, organic acids such as acetic acid, and halogenated hydrocarbons such as dichloromethane, chloroform and carbon tetrachloride.
  • peroxides such as hydrogen peroxide, peracetic acid, perbenzoic acid and m-chloroperbenzoic acid
  • hypochlorites such as sodium hypochlorite and potassium hypochlorite
  • an inert solvent including water, alcohols such as methanol and ethanol, organic acids such as acetic acid, and halogenated hydrocarbons such as dichloromethane
  • the next dechlorination of a compound of Formula (9) is carried out by such a method as catalytic hydrogenolysis using Raney nickel as a catalyst, method of using metal and metal salts such as lithium and sodium hydrogenolytic reduction with tin hydride, reduction with a metal-hydrogen complex compound such as lithium aluminum hydride, or electrolytic reduction, described in Shin Jikkenkagakukouza Vol. 14, Syntheses and Reactions of Organic Compounds [I] pages 22-30 (edited by the Chemical Society of Japan, published by Maruzen Co., Ltd.).
  • the obtained viscous liquid was purified on silica gel column chromatography (elution with n-hexane/ethyl acetate) to give 0.024 g of the title compound as white crystals. Melting point 86-88° C.
  • the obtained viscous liquid was purified on silica gel column chromatography (elution with n-hexane/ethyl acetate) to give 0.42 g of the title compound as white crystals. Melting point: 76-77° C.
  • the product was again purified on silica gel column chromatography to give the title compound with melting point of 102-103° C. as white crystals.
  • Table 3-1 Compounds 3-1 to 3-400, where R 4 is CH 3 , that are derived from Compounds Nos. from 1-1 to 1-400 in Table 1.
  • Table 3-2 Compounds 3-401 to 3-800, where R 4 is C 2 H 5 , that are derived from Compounds Nos. from 1-1 to 1-400 in Table 1.
  • Table 3-3 Compounds 3-801 to 3-1200, where R 4 is i-C 3 H 7 , that are derived from Compounds Nos. from 1-1 to 1-400 in Table 1.
  • Table 3-4 Compounds 3-1201 to 3-1600, where R 4 is t-C 4 H 9 , that are derived from Compounds Nos. from 1-1 to 1-400 in Table 1.
  • benzoic acid derivatives useful as intermediates for the preparation of agricultural chemicals and drugs can be produced simply, easily and industrially advantageously in a short process, using inexpensive cyclopentadiene derivatives and ethylene derivatives substituted with hetero rings as starting materials.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Benzoic acid derivatives useful as intermediates for the preparation of drugs and agricultural chemicals, particularly compounds having herbicidal activity; and easy and economical processes for the preparation of the same. The processes are specifically those represented by reaction formula for the preparation of compounds represented by general formulae (1) and (6).
Figure US06756497-20040629-C00001

Description

FIELD OF THE INVENTION
The present invention relates to benzoic acid derivatives useful as intermediates for the preparation of drugs and agricultural chemicals, particularly compounds having herbicidal activity, and to processes for the preparation thereof.
BACKGROUND ART
A method (A) of obtaining benzoic acid derivatives by reactions represented by the following reaction scheme,
Figure US06756497-20040629-C00002
between bicycloheptenone derivatives substituted with carboxylates and alcolates or the like is described in Tetrahedron, 42, 1741 (1986) and J. Org. Chem., 26, 2066 (1961).
However, there are no reports on reactions of bicycloheptenone derivatives substituted with hetero rings.
Known methods of dehalogenation of aromatic halogenated compounds include, for example, catalytic hydrogenolysis using palladium-carbon or Raney nickel as a catalyst, a method of using metal and metal salts such as lithium or sodium, hydrogenolytic reduction with tin hydride, reduction with metal-hydrogen complex compounds such as lithium aluminum hydride, and electrolytic reduction, which are described in Shin Jikkenkagakukouza, Vol. 14, Syntheses and Reactions of Organic Compounds [I] pages 22-30 (edited by the Chemical Society of Japan, published by Maruzen Co., Ltd.).
DISCLOSURE OF THE INVENTION
Substituted benzoic acid compounds, such as 4-alkylthiobenzoic acid derivatives, are important as intermediates for the preparation of agricultural chemicals and drugs. It has been desired to develop easy and industrially advantageous processes for the preparation of the said benzoic acid derivatives.
The present invention is directed to
(a) a benzoic acid derivative represented by Formula (1)
Figure US06756497-20040629-C00003
 (wherein R1 is hydrogen or C1-4 alkyl,
R2 is hydrogen or C1-6 alkyl, and
Q is an optionally substituted, saturated or unsaturated, 5- or 6-membered heterocyclic group containing 1 to 4 N, O or S atoms and combining with the benzene ring via a carbon atom);
(b) a process for the preparation of a benzoic acid derivative of the said Formula (1), characterized by acting a base on a bicycloheptenone derivative of Formula (2)
Figure US06756497-20040629-C00004
 (wherein R1 and Q are as defined above), in an appropriate solvent;
(c) a process for the preparation of a benzoic acid derivative of the said Formula (1), characterized by consisting of a stage of preparing a bicycloheptenone derivative of the said Formula (2) by hydrolysis of a bicycloheptene derivative of Formula (3)
Figure US06756497-20040629-C00005
 (wherein R1 are as defined above, and X is chlorine or C1-4 alkoxy and two X's may join to form a C2-3 alkylenedioxy group optionally substituted with C1-4 alkyl), and of acting a base and water or alcohol on a bicycloheptenone derivative of the said Formula (2) in an appropriate solvent;
(d) a process for the preparation of a bicycloheptene derivative of the said Formula (3), characterized by reacting a cyclopentadiene derivative of Formula (4)
Figure US06756497-20040629-C00006
 (wherein X is as defined above) with an ethylene derivative substituted with a hetero ring, of Formula (5)
Figure US06756497-20040629-C00007
 (wherein R1 and Q are defined above);
(e) a bicycloheptenone derivative of the said formula (2); and
(f) a process for the preparation of a benzoic acid derivative of Formula (6)
Figure US06756497-20040629-C00008
 (wherein R1, R2 and Q are as defined above and R4 is C1-6 alkyl), characterized by reacting a 4,5-dichlorobenzoic acid derivative of the said Formula (1), with a mercaptan of Formula R4SH (wherein R4 is as defined above) and a base or with a salt of mercaptan of Formula R4SH (wherein R4 is as defined above)
In the definitions of the compounds of the said Formulae (1) and (2), which are the compounds of the present invention, the compounds of Formula (3) of their precursors and the compounds of Formula (6),
R1 is hydrogen, or C1-4 alkyl such as methyl, ethyl, propyl, isopropyl n-butyl isobutyl s-butyl or t-butyl;
a R2 is hydrogen, or C1-6 alkyl such as methyl, ethyl, propyl, isopropyl, n-butyl, isobutyl, s-butyl t-butyl, n-pentyl, isopentyl, neopentyl, n-hexyl or isohexyl;
X is halogen such as chlorine, or C1-4 alkoxy such as methoxy, ethoxy, propoxy, isopropoxy or butoxy;
Two X's may join to form a C2-3 alkylenedioxy group, such as ethylenedioxy or trimethylenedioxy;
Further, the said C2-3 alkylenedioxy group may be substituted with C1-4 alkyl such as methyl, ethyl, propyl, isopropyl, n-butyl, isobutyl, s-butyl and t-butyl; and
Q is an optionally substituted, saturated or unsaturate 5- or 6-membered heterocyclic group containing 1 to 4 N, O or S atoms and combining with the benzene or bicycloheptane ring via a carbon atom.
Such hetero rings include, for example, 5-membered heterocyclic groups containing 1 to 4 N, O or S atoms, such as
2-furyl, 3-furyl,
2-thienyl, 3-thienyl,
2,3-dihydrofuran-2-yl, 2,3-dihydrofuran-3-yl, 2,3-dihydrofuran4-yl,2,3-dihydrofuran-5-yl, 2,5-dihydrofuran-2-yl, 2,5-dihydrofuran-3-yl,
2,3-dihydrothiophen-2-yl, 2,3-dihydrothiophen-3-yl, 2,3-dihydrothiophen-4-yl, 2,3-dihydrothiophen-5-yl, 2,5-dihydrothiophen-2-yl, 2,5-dihydrothiophen-3-yl,
pyrrol-2-yl, pyrrol-3-yl,
imidazol-2-yl, imidazol-4-yl, imidazol-5-yl,
2-imidazolin-2-yl, 2-imidazolin-4-yl, 2-imidazolin-5-yl,
pyrazol-3-yl, pyrozol-4-yl, pyrazol-5-yl,
oxazol-2-yl, oxazol-4-yl, oxazol-5-yl,
isoxazol-3-yl, isoxazol-4-yl, isoxazol-5-yl.
1,2,4-oxadiazol-3-yl, 1,2,4-oxadiazol-5-yl, 1,3,4-oxadiazol-2-yl, 1,2,3-oxadiazol-4-yl, 1,2,3-oxadiazol-5-yl, 1,2,5-oxadiazol-3-yl,
4-thiazolyl, 4-thiazolyl, 5-thiazolyl,
isothiazol-3-yl, isothiazol-4-yl, isothiazol-5-yl,
1,2,4-thiadiazol-3-yl, 1,2,4-thiadiazol-5-yl, 1,3,4-thiadiazol-2-yl, 1,2,3-thiadiazol-4-yl, 1,2,3-thiadiazol-5-yl, 1,2,5-thiadiazol-3-yl,
1,2,4-triazol-3-yl, 1,2,4-triazol-5-yl, 1,3,4-triazol-2-yl, 1,2,3-triazol-4-yl, 1,2,3-triazol-5-yl, tetrazol-5-yl,
2-pyrrolin-1-yl, 2-pyrrolin-2-yl, 2-pyrrolin-3-yl, 2-pyrrolin4-yl, 2-pyrrolin-5-yl,
2-oxazolin-2-yl, 2-oxazolin-4-yl, 2-oxazolin-5-yl, 3-oxazolin-2-yl, 3-oxazolin-4-yl, 3-oxazolin-5-yl, 4-oxazolin-2-yl, 4-oxazolin-4-yl, 4oxazolin-5-yl,
2-isoxazolin-3-yl, 2-isoxazolin-4-yl, 2-isoxazolin-5-yl,
3-isoxazolin-3-yl, 3-isoxazolin-4-yl, 3-isoxazolin-5-yl,
4-isoxazolin-3-yl, 4-isoxazolin-4-yl, 4-isoxazolin-5-yl,
2-thiazolin-2-yl, 4-thiazolin-4-yl, 4-thiazolin-5-yl,
2-isothiazolin-3-yl, 2-isothiazolin-4-yl, 2-isothiazolin-5-yl,
3-isothiazolin-3-yl, 3-isothiazolin-4-yl, 3-isothiazolin-5-yl,
4-isothiazolin-3-yl, 4-isothiazolin-4-yl, 4-isothiazolin-5-yl,
1-pyrazolin-3-yl, 1-pyrazolin-4-yl, 1-pyrazolin-5-yl,
2-pyrazolin-3-yl, 2-pyrazolin-4-yl, 2-pyrazolin-5-yl,
3-pyrazolin-3-yl, 3-pyrazolin-4-yl and 3-pyrazolin-5-yl; saturated 5-membered heterocyclic groups containing 1 to 4 N, O or S atoms, such as
2-pyrrolidinyl, 3-pyrrolidinyl,
2-tetrahydrofuranyl, 3-tetrahydrofuranyl,
2-tetrahydrothienyl, 3-tetrahydrothienyl,
2-oxazolidinyl, 4-oxazolidinyl, 5-oxazolidinyl,
3-isoxazolidinyl, 4-isoxazolidinyl, 5-isoxazolidinyl,
2-thiazolidinyl, 4-thiazolidinyl, 5-thiazolidinyl,
3-isothiazolidinyl, 4-isothiazolidinyl, 5-isothiazolidinyl,
2-imidazolidinyl, 4-imidazolidinyl,
1,2,4-oxadiazolidin-3-yl, 1,2,4-oxadiazolidin-5-yl, 1,3,4-oxadiazolidin-2-yl,
1,2,4-thiadiazolidin-3-yl, 1,2,4-thiadiazolidin-5-yl, 1,3,4-thiadiazolidin-2-yl,
1,3,4-triazolidin-2-yl,
1,3-dioxolan-2-yl, 1,3-dioxolan-4-yl,
1,3-dithiolan-2-yl, 1,3-dithiolan-4-yl, and
1,3-oxathiolan-2-yl; and
6-membered heterocyclic groups containing 1 to 4 N, O or S atoms, such as
2-pyridyl, 3-pyridyl, 4-pyridyl,
3-pyridazinyl, 4-pyridazinyl,
2-pyrimidinyl, 4-pyrimidinyl, 5-pyrimidinyl,
pyrazin-2-yl,
2H-pyran-3-yl, 2H-thiopyran-3-yl,
2-piperidinyl, 3-piperidinyl, 4-piperidinyl
2-piperadinyl,
2-morpholinyl, 3-morpholinyl,
5,6-dihydro-4H-1,3-thiazin-2-yl,
2-tetrahydropyranyl, 3-tetrahydropyranyl, 4-tetrahydropyranyl,
2-tetrahydrothiopyranyl, 3-tetrahydrothiopyranyl and 4-tetrahydrothiopyranyl.
These groups may have one or more, same or different, substituents at arbitrary positions of the hetero rings. Such substituents include, for example, C1-4 alkyl such as methyl, ethyl, propyl isopropyl, n-butyl, isobutyl, s-butyl and t-butyl, and C1-4 haloalkyl such as chloromethyl, dichloromethyl, trichloromethyl, fluoromethyl, difluoromethyl, trifluoromethyl, 1-fluoroethyl, 1,1-difluoroethyl, 2,2,2-trifluoroethyl and pentafluoroethyl.
Q is more preferably one of the following groups represented by Q-1 to Q-9.
Figure US06756497-20040629-C00009
In the above formulae, R3 is, for example, C1-4 alkyl such as methyl, ethyl, propyl, isopropyl, n-butyl, isobutyl, s-butyl or t-butyl, or C1-4 haloalkyl such as chloromethyl, dichloromethyl, trichloromethyl, fluoromethyl, difluoromethyl, trifluoromethyl, 1-fluoroethyl, 1,1-difluoroethyl, 2,2,2-trifluoroethyl or pentafluoroethyl, and n is 0 or an integer of 1 or 2.
Further, in the said Formula (6), R4 is C1-6 alkyl such as methyl, ethyl, propyl, isopropyl, n-butyl, isobutyl s-butyl, t-butyl, n-pentyl, isopentyl, neopentyl, n-hexyl or isohexyl.
The compounds of the present invention, represented by the said Formulae (2) and (3), may have stereoisomers, depending on substituents at positions 5 and 6. They are all covered by the present invention.
IMPLEMENTATION OF THE INVENTION
The compounds of the present invention may be produced by the following processes:
(Process 1) Process for the Preparation of a 4,5-dichlorobenzoic Acid Derivative from a Bicycloheptenone Derivative
Figure US06756497-20040629-C00010
(wherein R1, R2 and Q are as defined above).
A bicycloheptenone derivative (2) of Formula (2) is reacted with a base and water or alcohol in an appropriate solvent to give a compound of Formula (1).
Bases used for this reaction include, for example, alkali metal alcolates such as sodium methylate, sodium ethylate and potassium t-butoxide; alkali metal hydroxides such as sodium hydroxide and potassium hydroxide; alkaline earth metal hydroxides such as calcium hydroxide; alkali metal carbonates such as sodium carbonate, potassium carbonate and sodium hydrogen carbonate; and alkaline earth metal carbonates.
An amount of a base used is preferably 2 to 5 equivalents to 1 mole of a bicycloheptenone derivative (2).
Solvents able to be used for the reaction include alcohols such as methanol, ethanol, propanol, isopropanol, butanol and t-butanol; ethers such as diethyl ether and tetrahydrofuran (THF); hydrocarbons such as benzene and toluene; acetonitrile, dimethylformamide (DMF), water, toluene, benzene and the like, or mixtures of 2 or more of these solvents.
In the aforementioned reaction, it is particularly preferable to use alcoholic solvents, that is, alcohols, or mixed solvents of alcohol and other solvents such as water and alcohol or alcohol and ether.
In the above reaction, an ester (COOR2) having a portion corresponding to an alcohol (R2OH) used or the alkoxide portion of a metal alkoxide (MOR2) used can be obtained; for example, a methyl ester is obtained with the use of methyl alcohol and an ethyl ester from ethyl alcohol.
More preferred combinations of a base and a solvent include, for example, sodium methoxide and methanol (or a mixed solvent of methanol and other solvents), sodium ethoxide and ethanol (or a mixed solvent of ethanol and other solvents), sodium hydroxide and alcohol (or a mixed solvent of alcohol and other solvents), potassium hydroxide and alcohol (or a mixed solvent of alcohol and other solvents), and potassium t-butoxide and butanol.
In the case of the use of mixed solvents or aqueous solvents, carboxylic acids (R2=H) can be obtained. Solvents used together with water are favorably alcohols and ethers. As for bases, the aforementioned hydroxides or carbonates are preferably used.
In the case of the use of metal alkoxides, it is preferable to use corresponding alcohols, as described above. It is of course possible to use other alcohols.
Preferred reaction temperatures are between −10° C. and the boiling point of solvents used.
(Process 2)
Figure US06756497-20040629-C00011
(wherein R1, R2, Q and X are as defined above.)
A bicycloheptenone derivative (2) can be obtained by hydrolysis of a bicycloheptene derivative (3) with an acid such as hydrochloric acid or sulfuric acid.
That is, a compound (2) can be obtained by hydrolyzing a compound (3) without using a solvent or with a solvent including alcohols such as methanol, ethanol and t-butanol, ethers such as diethyl ether and tetrahydrofuran (THF) or aromatic hydrocarbons such as benzene and toluene, or a mixed solvent of two or more of these solvents, at temperature between −10° C. and the boiling point of solvents used.
After this, a target benzoic acid derivative can be prepared in the same way as that described in Process 1 above.
(Process 3)
Figure US06756497-20040629-C00012
(wherein R1, R2, Q and X are as defined above.)
A Diels-Alder reaction of a cyclopentadiene derivative (4) and an ethylene derivative substituted with a hetero ring (5) gives a bicycloheptene derivative (3).
The Diels-Alder reaction can be carried out according to methods described, for example, in Tetrahedron, 42, 1741-1744 (1986) or J. Org. Chem., 26, 2066-2072 (1961).
In the above reaction, cyclopentadienes and ethylene derivatives are reacted while heating. A molar ratio of the ethylene derivatives used in the reaction is 0.5 to 10 times in equivalent, preferably 1 to 3 equivalents, to 1 mole of cyclopentadienes. The reaction is carried out at temperature between room temperature and 25° C., more preferably between 70° C. and 200° C.
Although this reaction is usually carried out without solvents, solvents may be used. Examples of solvents used include aromatic hydrocarbons such as benzene, toluene, xylene, chlorobenzene and dichlorobenzene; alcohols such as ethanol, n-propyl alcohol, ethylene glycol, 1,3-butanediol and ethylene glycol monomethyl ether; ethers such as dimethoxyethane, dioxane and diethylene glycol dimethyl ether, amides such as N,N-dimethylformamide, N,N-dimethylacetamide, N-methylpyrolidone and N,N-dimethylimidazoline; hydrocarbons containing sulfur such as dimethylsulfoxide and sulfolane, and water.
The reaction proceeds more smoothly by adding a polymerization inhibitor such as hydroquinone in the presence of a base such as sodium hydrogen carbonate, potassium hydrogen carbonate, sodium carbonate or potassium carbonate.
After this, a target benzoic acid derivative can be produced in the same way as that in Process 2.
A compound of Formula (5), a starting material, can be prepared according to methods described, for example, in the following papers:
Chim. Ind. (Milan), 52 (1), 56 (1977): Preparation of 3-(1-propenyl)-1H-pyrrole;
Zh. Organ. Khim., 2, 417-423 (1966): Preparation of 5-(1-propenyl)-isoxazole;
J. Org. Chem., 62, 3671-3677 (1997): Preparation of 3(1-propenyl)-2-isoxazoline;
Heterocycles, 22 (11), 2475-2478 (1984): Preparation of 4(1-propenyl)pyridine; and
Heterocycles, 29(1), 103-114 (1989): Preparation of 5-(1-propenyl)-oxazole.
(Process 4)
Figure US06756497-20040629-C00013
(wherein R1, R2, R4 and Q are as defined above.)
In the process, a 4,5-dichlorobenzoic acid derivative of Formula (1) is reacted with an excessive amount of alkane thiol of Formula R4SH (R4 is as defined above) in an appropriate inert solvent in the presence of a base, to give a 4-alkylthiobenzoic acid derivative of Formula (6).
While doing so, the reaction proceeds more smoothly under the irradiation of light (of a specified wavelength). Various light sources can be used, including sunlight, fluorescent lights, mercury lamps, arc lamps and incandescent lamps. It is preferable to carry out the reaction under inert gas atmosphere, after the reaction system is sufficiently degassed.
The reaction may sometimes proceed more smoothly by adding water of 0.1 to 5 times in equivalent to the amount of 4,5-dichlorobenzoic acid derivative (1).
Particularly preferred solvents used for this reaction are amides, such as dimethylformamide DMF), N,N-dimethylacetamide and N-methylpyrolidone. However, solvents used are not restricted to them.
Examples of bases used include hydroxides such as sodium hydroxide and potassium hydroxide; carbonates such as sodium carbonate, sodium hydrogen carbonate, potassium carbonate and potassium hydrogen carbonate; and metal alcolates such as sodium methylate, sodium etheylate and potassium t-butoxide. In this case, a salt of alkane thiol, such as sodium or potassium salt of alkane thiol, prepared from an alkane thiol and a base beforehand, can be used for the reaction.
Amounts of base and alkane thiol used are preferably 2 to 20 equivalents to that of 4,5-dichlorobenzoic acid derivative (1).
Benzoic acid derivatives of Formula (6) can be produced by isolation of Compound (7) followed by reduction, as shown in the following reaction scheme:
Figure US06756497-20040629-C00014
To produce a compound of Formula (7), an equivalent of a compound of Formula (1) is reacted with about 1 to 3 equivalents of an alkane thiol of Formula R4SH (R4 is as defined above) in an inert solvent in the presence of an appropriate base.
In the reduction reaction from a compound of Formula (7) to a compound of Formula (6), the same alkane thiol (R4SH) as that used in the previous reaction can be used as a reducing agent. Further, other reducing agents such as hydrogen sulfide and aromatic thiols can be employed.
A compound of Formula (6) can be derived to a corresponding SO2R4 compound (8) by oxidation reaction of the SR4 group. This oxidation reaction may be carried out using an oxidizing agent including peroxides such as hydrogen peroxide, peracetic acid, perbenzoic acid and m-chloroperbenzoic acid, and hypochlorites such as sodium hypochlorite and potassium hypochlorite, in an inert solvent including water, alcohols such as methanol and ethanol organic acids such as acetic acid, and halogenated hydrocarbons such as dichloromethane, chloroform and carbon tetrachloride. The reaction proceeds smoothly in the temperature range from 0° C. to the boiling point of the solvent used.
Further, a SO2R4 compound (8) can be obtained by oxidation of a compound of the said Formula (7) and then a reduction reaction for dechlorination.
Figure US06756497-20040629-C00015
(wherein R1, R2, R4 and Q are as defined above.)
A compound of Formula (9) can be produced by oxidation of a compound of Formula (7). This oxidation reaction may be carried out using an oxidizing agent including peroxides such as hydrogen peroxide, peracetic acid, perbenzoic acid and m-chloroperbenzoic acid, and hypochlorites such as sodium hypochlorite and potassium hypochlorite, in an inert solvent including water, alcohols such as methanol and ethanol, organic acids such as acetic acid, and halogenated hydrocarbons such as dichloromethane, chloroform and carbon tetrachloride. The reaction proceeds smoothly in the temperature range from 0° C. to the boiling point of the solvent used.
The next dechlorination of a compound of Formula (9) is carried out by such a method as catalytic hydrogenolysis using Raney nickel as a catalyst, method of using metal and metal salts such as lithium and sodium hydrogenolytic reduction with tin hydride, reduction with a metal-hydrogen complex compound such as lithium aluminum hydride, or electrolytic reduction, described in Shin Jikkenkagakukouza Vol. 14, Syntheses and Reactions of Organic Compounds [I] pages 22-30 (edited by the Chemical Society of Japan, published by Maruzen Co., Ltd.).
The compounds of the present invention, intermediates and others can be obtained with usual post-treatments after the completion of the reactions.
The structures of the compounds of the present invention, intermediates and others were determined by IR, NMR, MS and other means.
BEST FORM TO IMPLEMENT THE INVENTION
The present invention is described in more detail in reference to Examples and Reference Examples.
In Examples, of the compounds of the present invention, (1S, 4R, 5R, 6S) and (1R, 4S, 5S, 6R) isomers are represented as “trans”, and (1S, 4R, 5R, 6R) and (1R, 4S, 5S, 6S) isomers as “cis”.
EXAMPLE 1 Preparation of ethyl 4,5-dichloro-2-methyl-3-(3-methylisooxazol-5-yl)benzoate
Figure US06756497-20040629-C00016
0.11 g of 6-methyl-5-(3-methylisoxazol-5-yl)-1,2,3,4-tetrachlorobicyclo[2.2.1]hept-2en-7-one (a mixture of trans:cis=1:1) was dissolved in 1 ml of ethanol, and 0.06 g of sodium ethylate was added, while cooling with ice. The resulting solution was stirred for an hour at room temperature. The reaction solution was poured into 50 ml of ice-water, and extracted with 30 ml of ethyl acetate twice. The organic layer was washed with saturated salt water and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure. The obtained viscous liquid was purified on silica gel column chromatography (elution with n-hexane/ethyl acetate) to give 0.024 g of the title compound as white crystals. Melting point 86-88° C.
EXAMPLE 2 Preparation of methyl 4,5-dichloro-2-methyl-3-(3-methylisoxazol-5-yl)benzoate
Figure US06756497-20040629-C00017
To 0.99 g of 6-methyl-cis-5-(3-methylisoxazol-5-yl)-7,7-dimethoxy-1,2,3,4-tetrachlorobicyclo[2.2]hept-2-ene was added 6.02 g of concentrated sulfuric acid, while cooling with ice. After returning to room temperature, the mixture was stirred for an hour. The resulting homogeneous solution was left undisturbed at room temperature for 15 hours. The reaction solution was poured into 20 ml of ice-water, and extracted with 20 ml of ethyl acetate twice. The organic layer was washed with aqueous sodium bicarbonate twice and then with saturated salt water, and dried over anhydrous magnesium sulfate. The magnesium sulfate was removed and the solvent was concentrated under reduced pressure to give 0.79 g of a crude product of 6-methyl-cis-5-(3-methylisoxazol-5-yl)-1,2,3,4-tetrachlorobicyclo[2.2.1]hept-2-en-7-one as a yellow sticky substance.
0.94 g of the obtained crude 6-methyl-cis-5-(3-methylisoxazol-5-yl)-1,2,3,4 tetrachlorobicyclo[2.2.1.]hept-2-en-7-one was dissolved in 10 ml of methanol, and 1.44 g of a 28% methanol solution of sodium methylate was dropped over 5 minutes, while cooling with ice. The resulting solution was stirred for 4 hours at room temperature, poured into 50 ml of ice-water, and extracted with 30 ml of ethyl acetate twice. The organic layer was washed with saturated salt water and dried over anhydrous magnesium sulfate. The solvent was concentrated under reduced pressure. The obtained viscous liquid was purified on silica gel column chromatography (elution with n-hexane/ethyl acetate) to give 0.42 g of the title compound as white crystals. Melting point: 76-77° C.
EXAMPLE 3 Preparation of 4,5-dichloro-2-methyl-5-(3-methylisoxazol-5-yl)benzoic acid
Figure US06756497-20040629-C00018
A solution of 156.9 g of 6-methyl-cis-5-(3-methylisoxazol-5-yl1,2,3,4-tetrachlorobicyclo[2.2.1]hept-2-en-7-one in 1150 ml of THF was dropped into a solution of 92 g of sodium hydroxide in 1150 ml of water at temperature between −3° C. and 0° C. over 1.5 hours. After the completion of the dropping, the cooling bath was removed. The reaction solution was stirred for 1.5 hours, while gradually rising the temperature to room temperature. After the reaction was completed, 500 ml of toluene was added to the reaction solution, and the aqueous layer was separated. Further, 500 ml of 1N aqueous solution of sodium hydroxide was added to the organic layer, and the aqueous layer was separated. The aqueous layers were combined, and 210 ml of concentrated hydrochloric acid was added to precipitate crystals. The crystals were separated by filtration, dissolved in 300 ml of ethyl acetate, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure to give 95.0 g of the title compound as white crystals. Melting point: 212-213° C.
EXAMPLE 4 Preparation of methyl 4,5-dichloro-2-methyl-3-(2-isoxazolin-3-yl)benzoate
Figure US06756497-20040629-C00019
To 1.0 g of 6-methyl-cis-5-(2-isoxazolin-3-yl)-7,7-dimethoxy-1,2,3,4-tetrachlorobicyclo[2.2.1]hept-2-ene was added 6.3 g of concentrated sulfuric acid, while cooling with ice. After returning to room temperature, the mixture was stirred for an hour. The resulting homogeneous solution was left undisturbed at room temperature for 15 hours. The reaction solution was poured into 20 ml of ice-water and extracted with 20 ml of ethyl acetate twice. The organic layer was washed with aqueous sodium bicarbonate twice and then with saturated salt water, and dried over anhydrous magnesium sulfate. The magnesium sulfate was removed and the solvent was concentrated under reduced pressure to give 0.94 g of a crude product of 6-methyl-cis-5-(2-isoxazolin-3-yl)-1,2,3,4-tetrachlorobicyclo[2.2.1]hept-2-en-7-one as a yellow sticky substance.
0.94 g of the obtained crude product was dissolved in 10 ml of methanol, and 1.5 g of a 28% methanol solution of sodium methylate was dropped over 5 minutes, while cooling with ice. The resulting solution was stirred at room temperature for 2 hours. The reaction solution was poured into 50 ml of ice-water, and extracted with 30 ml of ethyl acetate twice. The organic layer was washed with saturated salt water and dried over anhydrous magnesium sulfate. The solvent was concentrated under reduced pressure. The obtained viscous liquid was purified on silica gel column chromatography (with development solvents: n-hexane/ethyl acetate) to give 0.71 g of the title compound as white crystals. Melting point: 74-76° C.
The above procedure was repeated to produce ethyl 4,5-dichloro-2-methyl-3-(2-isoxazolin-3-yl)benzoate. Melting point: 96-97° C.
EXAMPLE 5 Preparation of 4.5-dichloro-2-methyl-3-(2-isoxazolin-3-yl)benzoate
Figure US06756497-20040629-C00020
1.6 g of a crude product of 6-methyl-cis-5-(2-isoxazolin-3-yl)-1,2,3,4-tetrachlorobicyclo[2.2.1]hept-2-en-7-one, obtained in the same manner as that in Example 4, was dissolved in 5 ml of tetrahydrofuran and 5 ml of water, and 14.6 g of 1N aqueous solution of sodium hydroxide was dropped over 5 minutes, while cooling with ice. The resulting solution was stirred at room temperature for 2 hours. The reaction solution was poured into 50 ml of ice-water, acidified in pH with hydrochloric acid, and extracted with 30 ml of ethyl acetate twice. The organic layer was washed with saturated salt water, and dried over anhydrous magnesium sulfate. The solvent was concentrated under reduced pressure. The obtained crystals were washed with n-hexane to give 0.6 g of the title compound as white crystals. Melting point: 203-206° C.
EXAMPLE 6 Preparation of 6-methyl-cis-5-(3-methylisoxazol-5-yl)-7,7-dimethoxy-1,2,3,4-tetrachlorobicyclo[2.2.1]hept-2-ene
Figure US06756497-20040629-C00021
2.15 g of 5,5-dimethoxy-1,2,3,4-tetrachlorocyclopenta-1,3-diene, 0.81 g of sodium hydrogen carbonate, 1.00 g of 1-(3-methylisoxazol-5-yl)-1-propene (an equivalent mixture of trans and cis isomers), 0.40 g of zinc iodide and 0.10 g of hydroquinone were mixed and heated with stirring at 150° C. for 8 hours. The reaction solution was cooled and 100 ml of water was added. The resulting solution was extracted with 200 ml of ethyl acetate. Insoluble matter present was removed by filtration. The organic layer was washed with saturated salt water and dried over anhydrous magnesium sulfate. The solvent was concentrated under reduced pressure. n-Hexane was added to the obtained crude product. The precipitated crystals were separated by filtration to give 0.92 g of the title compound. Melting point: 100-101° C.
Further, the above filtrate was purified on silica gel column chromatography (elution with benzene) to give 0.74 g of the tide compound.
EXAMPLE 7 Preparation of 6-methyl-cis-5-(3-methylisoxazol-5-yl)-7,7-dimethoxy-1,2,3,4-tetrachlorobicyclo[2.2.1]hept-2-ene
Figure US06756497-20040629-C00022
4.30 g of 5,5-dimethoxy-1,2,3,4-tetrachlorocyclopenta-1,3-diene, 1.00 g of 1-(3-methylisoxazol-5-yl)-1-propene (an equivalent mixture of trans and cis isomers) and 0.18 g of hydroquinone were added to 20 ml of 1,3-butanediol. The resulting mixture was heated at reflux for 7 hours. The reaction solution was cooled, poured into ice-water, and extracted with ethyl acetate. The organic layer was washed with saturated salt water, and dried over anhydrous magnesium sulfate. The solvent was concentrated under reduced pressure. n-Hexane was added to the obtained crude product. The separated viscous oil was removed. The n-hexane layer was concentrated under reduced pressure. The obtained crude product was purified on silica gel column chromatography (elution with benzene) to give 1.41 g of the title compound as white crystals. Melting point: 100-101° C.
EXAMPLE 8 Preparation of 6-methyl-5-(3-methylisoxazol-5-yl)-7,7-dimethoxy-1,2,3,4-tetrachlorobicyclo[2.2.1]hept-2-ene
Figure US06756497-20040629-C00023
1.07 g of 5,5-dimethoxy-1,2,3,4-tetrachlorocyclopenta-1,3-diene, 0.34 g of sodium hydrogen carbonate, 0.50g of trans-1-(3-methylisoxazol-5-yl)-1-propene and 0.05 g of hydroquinone were mixed and heated with stirring at 180° C. for 7 hours. The reaction solution was cooled and ethyl acetate was added. Insoluble matter was removed by filtration. Then the solvent was concentrated under reduced pressure. The obtained crude product was purified on silica gel column chromatography (elution with benzene) to give 0.70 g of the title compound as a mixture of isomers.
EXAMPLE 9 Preparation of 6-methyl-cis-5-(3-methylisoxazol-5-yl)-7,7-dimethoxy-1,2,3,4-tetrachlorobicyclo[2.2.1]hept-2-ene
Figure US06756497-20040629-C00024
64.39 g of 5,5-dimethoxy-1,2,3,4-tetrachlorocyclopenta-1,3-diene, 14.07 g of sodium hydrogen carbonate, 20.00 g of cis-1-(3-methylisoxazol-5-yl)-1-propene and 2.00 g of hydroquinone were mixed and heated with stirring at 120° C. for 6 hours. The reaction solution was cooled and 500 ml of water was added. The resulting solution was extracted with ethyl acetate three times. Insoluble matter present was removed by filtration. The organic layer was washed with saturated salt water and dried over anhydrous magnesium sulfate.
The solvent was concentrated under reduced pressure. n-Hexane was added to the obtained crude product. The precipitated crystals were separated by filtration to give 45.81 g of the title compound. Melting point: 100-101° C.
Further, the filtrate after the filtration of the crystals was purified on silica gel column chromatography (elution with benzene) to give 4.50 g of the title compound.
1H-NMR data of isomers (CDCl3, δppm) cis isomer
0.83 (d, 3H), 2.30 (s, 3H), 3.08 (m, 1H), 3.58 (s, 3H), 3.66 (s, 3H), 4.17 (d, 1H), 6.02 (s, 1H) trans isomer-1
1.40 (d, 3H), 2.30 (s, 3H), 2.37 (m, 1H), 3.58 (s, 3H), 3.62 (d, 1H), 3.66 (s, 3H), 6.00 (s, 1H) trans isomer-2
1.09 (d, 3H), 2.34 (s, 3H), 2.84 (d, 1H), 3.07 (m, 1H), 3.50 (s, 3H), 3.57 (s, 3H), 6.19 (s, 1H)
EXAMPLE 10 Preparation of 6-methyl-cis-5-(2-isoxazolin-3-yl)-7,7-dimethoxy-1,2,3,4-tetrachlorobicyclo[2.2.1]hept-2-ene
Figure US06756497-20040629-C00025
2.14 g of 5,5-dimethoxy-1,2,3,4-tetrachlorocyclopenta-1,3-diene, 0.46 g of sodium hydrogen carbonate and 0.6 g of cis-1-(2-isoxazolin-3-yl)-1-propene were mixed and heated with stirring at 120° C. for 6 hours. The reaction solution was cooled to room temperature and ice-water was added. The resulting solution was extracted with 200 ml of ethyl acetate. The organic layer was washed with water and dried over anhydrous magnesium sulfate. The solvent was concentrated under reduced pressure. The obtained oily product was purified on silica gel column chromatography (elution with n-hexane/ethyl acetate) to give 1.0 g of the title compound. Melting point: 98-100° C.
EXAMPLE 11 Preparation of 6-methyl-trans-5-(2-isoxazolin-3-yl)-7,7-dimethoxy-1,2,3,4-tetrachlorobicyclo[2.2.1]hept-2-ene
Figure US06756497-20040629-C00026
2.62 g of 5,5-dimethoxy-1,2,3,4-tetrachlorocyclopenta-1,3-diene, 1.1 g of sodium hydrogen carbonate and 1.0 g of trans-1-(2-isoxazolin-3-yl)-1-propene were mixed and heated with stirring at 200° C. for 20 hours. The reaction solution was cooled to room temperature, poured into ice-water, and extracted with ethyl acetate. The organic layer was washed with water and dried over anhydrous magnesium sulfate. The solvent was concentrated under reduced pressure. The obtained oily product was purified on silica gel column chromatography (elution with n-hexane/ethyl acetate) to give 1.8 g of the title compound. nD 19.9 1.5087
EXAMPLE 12 Preparation of ethyl 2-methyl-3-(3-methylisoxazol-5-yl)-4-methylthiobenzoate
Figure US06756497-20040629-C00027
0.50 g of ethyl 4,5-dichloro-2-methyl-3-(3-methylisoxazol-5-yl)benzoate and 4.40 g of potassium carbonate were added to 15 ml of DMF, and a solution of 1.53 g of methyl mercaptan dissolved in 5 ml of DMF was dropped at room temperature. The resulting solution was further stirred for 19.5 hours. Then, the reaction solution was poured into ice-water and extracted with ethyl acetate. The organic layer was washed with water and then with saturated salt water, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The obtained crude product was purified on silica gel column chromatography to give 0.42 g of the title compound as white crystals. Melting point: 72-74° C.
EXAMPLE 13 Preparation of ethyl 2-methyl-3-(3-methylisoxazol-5-yl)-4-methylthiobenzoate
Figure US06756497-20040629-C00028
4.48 g of ethyl 4,5-dichloro-2-methyl-3-(3-methylisoxazol-5-yl)benzoate and 3.00 g of potassium carbonate were added to 100 ml of DMF, and 2.1 g of methyl mercaptan gas was blown into the reaction system at room temperature. The resulting solution was further stirred at room temperature for 15 hours. The reaction solution was poured into ice-water and extracted with ethyl acetate. The organic layer was washed with water and then with saturated salt water, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure to give 4.40 g of ethyl 5-chloro-2-methyl-3-(3-methylisoxazol-5-yl)-4-methylthiobenzoate as white crystals. Melting point: 79-82° C.
0.50 g of the obtained ethyl 5-chloro-2-methyl-3-(3-methylisoxazol-5-yl)-4-methylthiobenzoate and 1.06 g of potassium carbonate were added to 15 ml of DMF, and further a solution of 0.36 g of methyl mercaptan dissolved in 5 ml of DMF was dropped at room temperature. The resulting solution was stirred at room temperature for 23 hours. The same procedure as that in Example 1 was repeated to give 0.29 g of the title compound as white crystals. 0.08 g of ethyl 5-chloro-2-methyl-3-(3-methylisoxazol-5-yl)-4-methylthiobenzoate was recovered.
EXAMPLE 14 Preparation of methyl 3-(2-isoxazolin-3-yl)-2-methyl-4-methylthiobenzoate
Figure US06756497-20040629-C00029
10 ml of degassed DMF was placed in a colorless, transparent glass container, and 420 mg of methyl mercaptan was blown in to dissolve. Then 600 mg of potassium carbonate and 500 mg of methyl 4,5-dichloro-3-(2-isoxazolin-3-yl)-2-methylbenzoate were added one by one. The resulting solution was stirred with a Teflon magnetic stirrer at room temperature with light shielded under the nitrogen atmosphere. After stirring it for an hour, it was confirmed by NMR that methyl 5-chloro-3-(2-isoxazolin-3-yl)-2-methyl-4-methylthiobenzoate was a major product. Succeedingly, the reaction system was stirred at 40° C. for 2 hours, while irradiating with white fluorescent light. The reaction solution was poured into ice-water, and extracted with ether-chloroform (5:1) and then with ether. The organic layers were washed with water, dried over sodium sulfate, and concentrated under reduced pressure. The obtained residue was purified on silica gel column chromatography (elution with n-hexane/ethyl acetate=95/5) to give 424 mg of the title compound as white crystals. Melting point: 109-111° C.
EXAMPLE 15 Preparation of t-butyl 2-methyl-3-(3-methylisoxazol-5-yl)-4-methylthiobenzoate
Figure US06756497-20040629-C00030
27 mg of water was added to 10 ml of DMF, and 360 mg of methyl mercaptan was blown into the resulting solution. Then the reaction system was purged by nitrogen. To the resulting solution were added 518 mg of potassium carbonate and 513 mg of t-butyl 4,5-dichloro-2-methyl-3-(3-methylisoxazol-5-yl)benzoate to stir at room temperature for 20 hours. The reaction solution was poured into 25 ml of ice-water and extracted with 25 ml of ether. The organic layer was washed with water and dried over anhydrous sodium sulfate. The solvent was distilled off under reduced pressure. The obtained crude product was purified on silica gel column chromatography (elution with n-hexane/ethyl acetate=95/5) to give 484 mg of the title compound with 83% purity as a white solid. (The purity was determined by NMR spectra.) The product was again purified on silica gel column chromatography to give the title compound with melting point of 102-103° C. as white crystals.
EXAMPLE 16 Preparation of ethyl 2-methyl-3-(2-isoxazolin-3-yl)-4-methylthiobenzoate
Figure US06756497-20040629-C00031
Into a 10-ml round-bottomed flask purged by nitrogen were placed 7.9 mg of water, 1.1 ml of DMF and a solution of 105 mg of methyl mercaptan in 1.5 ml of DMF, and then 151 mg of potassium carbonate and 132 mg of ethyl 4,5-dichloro-3-(2-isoxazol-3-yl)-2-methylbenzoate were added. The DMF used here was purged by nitrogen beforehand. The resulting mixture was stirred with a magnetic stirrer at room temperature for 3 hours and 45 minutes under the irradiation of 40W fluorescent light. The reaction solution was poured into 20 ml of ice-water, and extracted with 20 ml of diethyl ether. The organic layer was washed with water, and dried over anhydrous sodium sulfate. The solvent was distilled off under reduced pressure. The obtained crude product was purified on silica gel column chromatography (elution with n-hexane/ethyl acetate=95/5) to give 87.8 mg of the title compound as white crystals. Melting point: 93˜94° C.
EXAMPLE 17 Preparation of ethyl 4-ethylthio-2-methyl-3-(3-methylisoxazol-5-yl)benzoate
Figure US06756497-20040629-C00032
Into a 250-ml round-bottomed flask were placed 0.311 g of ethyl mercaptan, 0.018 g of water and 6 ml of DMF, and then 0.346 g of potassium carbonate and 0.314 g of ethyl 4,5-dichloro-2-methyl-3-(3-methylisoxazol-5-yl)benzoate were adder The resulting mixture was stirred with a magnetic stirrer at room temperature for 6 hours under the irradiation of 40W fluorescent light. The reaction solution was poured into 25 ml of ice-water, and extracted with 25 ml of diethyl ether. The organic layer was washed with water, and dried over anhydrous sodium sulfate. The solvent was distilled off under reduced pressure. The obtained crude product was purified on silica gel column chromatography (elution with n-hexane/ethyl acetate=95/5) to give 0.132 g of the title compound as white crystals. Melting point: 39-40° C.
The above procedure was repeated to produce methyl 4-methylthio-2-methyl-3-(3-methylisoxazol-5-yl)benzoate by reacting methyl 4,5-dichloro-2-methyl-3-(3-methylisoxazol-5-yl)benzoate and methyl mercaptan. Melting point: 94-95° C.
(REFERENCE EXAMPLES)
Examples of the preparation of the aforementioned 4-SO2R4 compounds (8) are described in reference to Reference Examples.
Reference Example 1
Preparation of ethyl 2-methyl-3-(3-methylisoxazol-5-yl)-4-methylsulfonylbenzoate
Figure US06756497-20040629-C00033
0.30 g of ethyl 5-chloro-2-methyl-3-(3-methylisoxazol-5-yl)-4-methylsulfonylbenzoate was dissolved in 20 ml of ethanol. After the reaction system was purged by nitrogen, 0.02 g of 5% palladium-carbon was added. The system was purged by hydrogen. A rubber ball filled with hydrogen was attached and the solution was stirred at room temperature for 3 hours. The palladium-carbon was removed from the reaction solution by filtration. The solvent was distilled off under reduced pressure to give 0.28 g of the title compound as white crystals. Melting point: 83-86° C.
Reference Example 2
Preparation of ethyl 5-chloro-2-methyl-3-(3-methylisoxazol-5-yl)-4-methylsulfonylbenzoate
Figure US06756497-20040629-C00034
4.40 g of ethyl-5-chloro-2-methyl-3-(3-methylisoxazol-5-yl)-4-methylthiobenzoate was dissolved in 50 ml of chloroform, and 12.70 g of 55% m-chloroperbenzoic acid was added at room temperature. The resulting solution was stirred at room temperature for 19 hours. Precipitated crystals were separated from the reaction solution by filtration. The filtrate was washed with 80 ml of a 4% aqueous solution of sodium hydroxide. The organic layer was dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure to give 4.49 g of the title compound as white crystals. Melting point: 126-129° C.
Representative examples of the compounds of Formulae (1) and (2) of the present invention, including those in the above examples, are shown in Tables 1 and 2. The abbreviations of Q's in the tables have the following meanings:
Q1: isoxazol-5-yl, Q2: 3-methylisoxazol-5-yl, Q3: isoxazol-3-yl, Q4: 2-isoxazolin-3-yl, Q5: oxazol-2-yl, Q6: oxazol-4-yl, Q7: oxazol-5-yl, Q8: thiazol-2-yl, Q9: thiazol-4-yl, Q10: thiazol-5-yl, Q11: pyrazol-3-yl, Q12: 1-methyl-pyrazol-3-yl, Q13: 2-pyridyl: Q14: 3-pyridyl, Q15: 4-pyridyl, Q16: pyrimidin-2-yl, Q17: pyrimidin-4-yl, Q18: pyrimidin-5-yl, Q19: 1,3-dioxoran-2-yl, and Q20: 1,3-dioxan-2-yl
TABLE 1
(1)
Figure US06756497-20040629-C00035
Compound No. Q
Table 1-1
R1: CH3
R2: H
1-1 Q1
1-2 Q2
1-3 Q3
1-4 Q4
1-5 Q5
1-6 Q6
1-7 Q7
1-8 Q8
1-9 Q9
1-10 Q10
1-11 Q11
1-12 Q12
1-13 Q13
1-14 Q14
1-15 Q15
1-16 Q16
1-17 Q17
1-18 Q18
1-19 Q19
1-20 Q20
Table 1-2
R1: CH3
R2: CH3
1-21 Q1
1-22 Q2
1-23 Q3
1-24 Q4
1-25 Q5
1-26 Q6
1-27 Q7
1-28 Q8
1-29 Q9
1-30 Q10
1-31 Q11
1-32 Q12
1-33 Q13
1-34 Q14
1-35 Q15
1-36 Q16
1-37 Q17
1-38 Q18
1-39 Q19
1-40 Q20
Table 1-3
R1: CH3
R2: C2H5
1-41 Q1
1-42 Q2
1-43 Q3
1-44 Q4
1-45 Q5
1-46 Q6
1-47 Q7
1-48 Q8
1-49 Q9
1-50 Q10
1-51 Q11
1-52 Q12
1-53 Q13
1-54 Q14
1-55 Q15
1-56 Q16
1-57 Q17
1-58 Q18
1-59 Q19
1-60 Q20
Table 1-4
R1: CH3
R2: n-C3H7
1-61 Q1
1-62 Q2
1-63 Q3
1-64 Q4
1-65 Q5
1-66 Q6
1-67 Q7
1-68 Q8
1-69 Q9
1-70 Q10
1-71 Q11
1-72 Q12
1-73 Q13
1-74 Q14
1-75 Q15
1-76 Q16
1-77 Q17
1-78 Q18
1-79 Q19
1-80 Q20
Table 1-5
R1: CH3
R2: i-C3H7
1-81 Q1
1-82 Q2
1-83 Q3
1-84 Q4
1-85 Q5
1-86 Q6
1-87 Q7
1-88 Q8
1-89 Q9
1-90 Q10
1-91 Q11
1-92 Q12
1-93 Q13
1-94 Q14
1-95 Q15
1-96 Q16
1-97 Q17
1-98 Q18
1-99 Q19
1-100 Q20
Table 1-6
R1: CH3
R2: n-C4H9
1-101 Q1
1-102 Q2
1-103 Q3
1-104 Q4
1-105 Q5
1-106 Q6
1-107 Q7
1-108 Q8
1-109 Q9
1-110 Q10
1-111 Q11
1-112 Q12
1-113 Q13
1-114 Q14
1-115 Q15
1-116 Q16
1-117 Q17
1-118 Q18
1-119 Q19
1-120 Q20
Table 1-7
R1: CH3
R2: n-C4H9 a
1-121 Q1
1-122 Q2
1-123 Q3
1-124 Q4
1-125 Q5
1-126 Q6
1-127 Q7
1-128 Q8
1-129 Q9
1-130 Q10
1-131 Q11
1-132 Q12
1-133 Q13
1-134 Q14
1-135 Q15
1-136 Q16
1-137 Q17
1-138 Q18
1-139 Q19
1-140 Q20
Table 1-8
R1: CH3
R2: t-C4H9
1-141 Q1
1-142 Q2
1-143 Q3
1-144 Q4
1-145 Q5
1-146 Q6
1-147 Q7
1-148 Q8
1-149 Q9
1-150 Q10
1-151 Q11
1-152 Q12
1-153 Q13
1-154 Q14
1-155 Q15
1-156 Q16
1-157 Q17
1-158 Q18
1-159 Q19
1-160 Q20
Table 1-9
R1: CH3
R2: i-C5H11
1-161 Q1
1-162 Q2
1-163 Q3
1-164 Q4
1-165 Q5
1-166 Q6
1-167 Q7
1-168 Q8
1-169 Q9
1-170 Q10
1-171 Q11
1-172 Q12
1-173 Q13
1-174 Q14
1-175 Q15
1-176 Q16
1-177 Q17
1-178 Q18
1-179 Q19
1-180 Q20
Table 1-10
R1: CH3
R2: t-C5H11
1-181 Q1
1-182 Q2
1-183 Q3
1-184 Q4
1-185 Q5
1-186 Q6
1-187 Q7
1-188 Q8
1-189 Q9
1-190 Q10
1-191 Q11
1-192 Q12
1-193 Q13
1-194 Q14
1-195 Q15
1-196 Q16
1-197 Q17
1-198 Q18
1-199 Q19
1-200 Q20
Table 1-11
R1: C2H5
R2: H
1-201 Q1
1-202 Q2
1-203 Q3
1-204 Q4
1-205 Q5
1-206 Q6
1-207 Q7
1-208 Q8
1-209 Q9
1-210 Q10
1-211 Q11
1-212 Q12
1-213 Q13
1-214 Q14
1-215 Q15
1-216 Q16
1-217 Q17
1-218 Q18
1-219 Q19
1-220 Q20
Table 1-12
R1: C2H5
R2: CH3
1-221 Q1
1-222 Q2
1-223 Q3
1-224 Q4
1-225 Q5
1-226 Q6
1-227 Q7
1-228 Q8
1-229 Q9
1-230 Q10
1-231 Q11
1-232 Q12
1-233 Q13
1-234 Q14
1-235 Q15
1-236 Q16
1-237 Q17
1-238 Q18
1-239 Q19
1-240 Q20
Table 1-13
R1: C2H5
R2: C2H5
1-241 Q1
1-242 Q2
1-243 Q3
1-244 Q4
1-245 Q5
1-246 Q6
1-247 Q7
1-248 Q8
1-249 Q9
1-250 Q10
1-251 Q11
1-252 Q12
1-253 Q13
1-254 Q14
1-255 Q15
1-256 Q16
1-257 Q17
1-258 Q18
1-259 Q19
1-260 Q20
Table 1-14
R1: C2H5
R2: n-C3H7
1-261 Q1
1-262 Q2
1-263 Q3
1-264 Q4
1-265 Q5
1-266 Q6
1-267 Q7
1-268 Q8
1-269 Q9
1-270 Q10
1-271 Q11
1-272 Q12
1-273 Q13
1-274 Q14
1-275 Q15
1-276 Q16
1-277 Q17
1-278 Q18
1-279 Q19
1-280 Q20
Table 1-15
R1: C2H5
R2: i-C3H7
1-281 Q1
1-282 Q2
1-283 Q3
1-284 Q4
1-285 Q5
1-286 Q6
1-287 Q7
1-288 Q8
1-289 Q9
1-290 Q10
1-291 Q11
1-292 Q12
1-293 Q13
1-294 Q14
1-295 Q15
1-296 Q16
1-297 Q17
1-298 Q18
1-299 Q19
1-300 Q20
Table 1-16
R1: C2H5
R2: n-C4H9
1-301 Q1
1-302 Q2
1-303 Q3
1-304 Q4
1-305 Q5
1-306 Q6
1-307 Q7
1-308 Q8
1-309 Q9
1-310 Q10
1-311 Q11
1-312 Q12
1-313 Q13
1-314 Q14
1-315 Q15
1-316 Q16
1-317 Q17
1-318 Q18
1-319 Q19
1-320 Q20
Table 1-17
R1: C2H5
R2: s-C4H9
1-321 Q1
1-322 Q2
1-323 Q3
1-324 Q4
1-325 Q5
1-326 Q6
1-327 Q7
1-328 Q8
1-329 Q9
1-330 Q10
1-331 Q11
1-332 Q12
1-333 Q13
1-334 Q14
1-335 Q15
1-336 Q16
1-337 Q17
1-338 Q18
1-339 Q19
1-340 Q20
Table 1-18
R1: C2H5
R2: t-C4H9
1-341 Q1
1-342 Q2
1-343 Q3
1-344 Q4
1-345 Q5
1-346 Q6
1-347 Q7
1-348 Q8
1-349 Q9
1-350 Q10
1-351 Q11
1-352 Q12
1-353 Q13
1-354 Q14
1-355 Q15
1-356 Q16
1-357 Q17
1-358 Q18
1-359 Q19
1-360 Q20
Table 1-19
R1: C2H5
R2: i-C5H11
1-361 Q1
1-362 Q2
1-363 Q3
1-364 Q4
1-365 Q5
1-366 Q6
1-367 Q7
1-368 Q8
1-369 Q9
1-370 Q10
1-371 Q11
1-372 Q12
1-373 Q13
1-374 Q14
1-375 Q15
1-376 Q16
1-377 Q17
1-378 Q18
1-379 Q19
1-380 Q20
Table 1-20
R1: C2H5
R2: t-C5H11
1-381 Q1
1-382 Q2
1-383 Q3
1-384 Q4
1-385 Q5
1-386 Q6
1-387 Q7
1-388 Q8
1-389 Q9
1-390 Q10
1-391 Q11
1-392 Q12
1-393 Q13
1-394 Q14
1-395 Q15
1-396 Q16
1-397 Q17
1-398 Q18
1-399 Q19
1-400 Q20
TABLE 2
(2)
Figure US06756497-20040629-C00036
Compound No. Q
Table 2-1
R1: CH3
2-1 Q1
2-2 Q2
2-3 Q3
2-4 Q4
2-5 Q5
2-6 Q6
2-7 Q7
2-8 Q8
2-9 Q9
2-10 Q10
2-11 Q11
2-12 Q12
2-13 Q13
2-14 Q14
2-15 Q15
2-16 Q16
2-17 Q17
2-18 Q18
2-19 Q19
2-20 Q20
Table 2-2
R1: C2H5
2-21 Q1
2-22 Q2
2-23 Q3
2-24 Q4
2-25 Q5
2-26 Q6
2-27 Q7
2-28 Q8
2-29 Q9
2-30 Q10
2-31 Q11
2-32 Q12
2-33 Q13
2-34 Q14
2-35 Q15
2-36 Q16
2-37 Q17
2-38 Q18
2-39 Q19
2-40 Q20
TABLE 3
(6)
Figure US06756497-20040629-C00037
Table 3-1
Compounds 3-1 to 3-400, where R4 is CH3, that are derived from
Compounds Nos. from 1-1 to 1-400 in Table 1.
Table 3-2
Compounds 3-401 to 3-800, where R4 is C2H5, that are derived from
Compounds Nos. from 1-1 to 1-400 in Table 1.
Table 3-3
Compounds 3-801 to 3-1200, where R4 is i-C3H7, that are derived from
Compounds Nos. from 1-1 to 1-400 in Table 1.
Table 3-4
Compounds 3-1201 to 3-1600, where R4 is t-C4H9, that are derived from
Compounds Nos. from 1-1 to 1-400 in Table 1.
Applicability in Industry
As described above, according to the present invention, benzoic acid derivatives useful as intermediates for the preparation of agricultural chemicals and drugs, particularly compounds having herbicidal activity, can be produced simply, easily and industrially advantageously in a short process, using inexpensive cyclopentadiene derivatives and ethylene derivatives substituted with hetero rings as starting materials.
For example, reactions of compounds of Formula (6), which are produced according to the present invention, with 3-hydroxypyrazoles give herbicides disclosed in WO 96/26206, WO 97/41118 and others.

Claims (5)

What is claimed is:
1. A process for the preparation of a substituted benzoic acid of Formula (1)
Figure US06756497-20040629-C00038
wherein R1is hydrogen or C1-4 alkyl, R2 is hydrogen or C1-6 alkyl, and Q is an optionally substituted, saturated or unsaturated, 5- or 6-membered heterocyclic group wherein said heterocyclic group is selected from the group consisting of:
a) a five member heterocyclic ring having at least one heteroatom which is selected from the group consisting of N, O, or S, and where the heterocyclic group is linked to the benzene ring via a carbon atom; or
b) a six member heterocyclic ring having at least one heteroatom which is selected from the group consisting of N, O, or S, and where the heterocyclic group is linked to the benzene ring via a carbon atom;
which comprises reacting a substituted bicycloheptenone of Formula (2)
Figure US06756497-20040629-C00039
wherein R1 is as defined above and Q
Figure US06756497-20040629-C00040
is an optionally substituted, saturated or unsaturated, 5- or 6-membered heterocyclic group wherein said heterocyclic group is selected from the group consisting of:
a) a five member heterocyclic ring having at least one heteroatom which is selected from the group consisting of N, O, or S, and where the heterocyclic group is linked to the benzene ring via a carbon atom; or
b) a six member heterocyclic ring having at least one heteroatom which is selected from the group consisting of N, O, or S, and where the heterocyclic group is linked to the benzene ring via a carbon atom;
with a base and water or alcohol of Formula R2OH, wherein R2 is hydrogen or C1-6 alkyl, in an appropriate solvent, and wherein the base is an alkali metal alkoxide, all alkali metal hydroxide or an alkaline earth metal hydroxide, the alcohol is methanol, ethanol, propanol, isopropanol, butanol or t-butanol, and the solvent is methanol, ethanol, propanol, isopropanol, butanol or t-butanol, or THF.
2. A process for the preparation of a substituted benzoic acid of Formula (1)
Figure US06756497-20040629-C00041
wherein R1 is hydrogen or C1-4 alkyl, R2 is hydrogen or C1-6 alkyl, and Q is selected from the group consisting of Q-1, Q-2, Q-3, Q-4, Q-5, Q-6, Q-7, Q-8 and Q-9
Figure US06756497-20040629-C00042
wherein R3 is C1-4 alkyl or C1-4 haloalkyl, and n is 0 or an integer of 1 or 2, which comprises having a stage for the preparation of a substituted bicycloheptenone of Formula (2)
Figure US06756497-20040629-C00043
wherein R1 and Q are as defined above by hydrolysis of a substituted bicycloheptene of Formula (3)
Figure US06756497-20040629-C00044
wherein R1 and Q are as defined above, and X is chlorine or C1-4 alkoxy; and the two X's may join together to form a C2-3 alkylenedioxy group optionally substituted with C1-4 alkyl, and a stage of reacting the substituted bicycloheptenone of the above Formula (2) with a base and water or alcohol in an appropriate solvent, and wherein the base is an alkali metal alkoxide, an alkali metal hydroxide or an alkaline earth metal hydroxide, the alcohol is methanol, ethanol, propanol, isopropanol, butanol or t-butanol, and the solvent is methanol, ethanol, propanol, isopropanol, butanol or t-butanol, or THF.
3. A process for the preparation of a substituted benzoic acid of the above Formula (1) according to claim 1, in which the base is one or more compounds selected from the group consisting of alkali metal alkoxides, alkali metal hydroxides and alkaline earth metal hydroxides.
4. A process according to claim 1, in which the solvent is an alcohol or a solvent containing an alcohol.
5. A process according to claim 2, in which the hetero ring represented by Q is a group selected from the following group consisting of Q-1, Q-2, Q-3, Q-4, Q-5, Q-6, Q-7, Q-8 and Q-9
Figure US06756497-20040629-C00045
wherein R3 is C1-4 alkyl or C1-4 haloalkyl, and n is 0 or an integer of 1 or 2.
US09/720,825 1998-07-14 1999-07-13 Benzoic acid derivatives and processes for the preparation thereof Expired - Fee Related US6756497B1 (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
JP19912598 1998-07-14
JP10-199125 1998-07-14
JP10-199126 1998-07-14
JP19912698 1998-07-14
JP6485699 1999-03-11
JP11-064856 1999-03-11
JP12293999 1999-04-28
JP11-122939 1999-04-28
PCT/JP1999/003773 WO2000003988A1 (en) 1998-07-14 1999-07-13 Novel benzoic acid derivatives and processes for the preparation thereof

Publications (1)

Publication Number Publication Date
US6756497B1 true US6756497B1 (en) 2004-06-29

Family

ID=27464496

Family Applications (1)

Application Number Title Priority Date Filing Date
US09/720,825 Expired - Fee Related US6756497B1 (en) 1998-07-14 1999-07-13 Benzoic acid derivatives and processes for the preparation thereof

Country Status (4)

Country Link
US (1) US6756497B1 (en)
EP (1) EP1097925B1 (en)
DE (1) DE69933222T2 (en)
WO (1) WO2000003988A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9398768B2 (en) 2012-04-27 2016-07-26 Basf Se Substituted N-(tetrazol-5-yl)- and N-(triazol-5-yl)pyridin-3-yl-carboxamide compounds and their use as herbicides
US9902704B2 (en) 2013-10-10 2018-02-27 Basf Se Substituted N-(tetrazol-5-yl)- and N-(triazol-5-yl)arylcarboxamide compounds and their use as herbicides
US9926284B2 (en) 2013-07-18 2018-03-27 Basf Se Substituted N-(1,2,4-triazol-3-yl)Arylcarboxamide compounds and their use as herbicides

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4804615B2 (en) * 2000-09-12 2011-11-02 日本曹達株式会社 Method for producing bicycloheptene derivative
MX2014005175A (en) 2011-11-14 2014-05-28 Basf Se Substituted 1,2,5-oxadiazole compounds and their use as herbicides.
EA027847B1 (en) 2012-04-27 2017-09-29 Басф Се Substituted n-(tetrazol-5-yl)- and n-(triazol-5-yl)arylcarboxamide compounds and their use as herbicides
WO2014184058A1 (en) 2013-05-15 2014-11-20 Basf Se Substituted 1,2,5-oxadiazole compounds and their use as herbicides
WO2014184016A1 (en) 2013-05-15 2014-11-20 Basf Se Substituted n-(tetrazol-5-yl)- and n-(triazol-5-yl)arylcarboxamide compounds and their use as herbicides
WO2015052178A1 (en) 2013-10-10 2015-04-16 Basf Se 1,2,5-oxadiazole compounds and their use as herbicides
WO2015052173A1 (en) 2013-10-10 2015-04-16 Basf Se Tetrazole and triazole compounds and their use as herbicides
EP2907807A1 (en) 2014-02-18 2015-08-19 Basf Se Benzamide compounds and their use as herbicides
WO2017102275A1 (en) 2015-12-17 2017-06-22 Basf Se Benzamide compounds and their use as herbicides
AU2018276360A1 (en) 2017-05-30 2019-12-19 Basf Se Benzamide compounds and their use as herbicides II
CA3063304A1 (en) 2017-05-30 2018-12-06 Basf Se Benzamide compounds and their use as herbicides
AR112112A1 (en) 2017-06-20 2019-09-18 Basf Se BENZAMIDE COMPOUNDS AND THEIR USE AS HERBICIDES
AR112342A1 (en) 2017-07-21 2019-10-16 Basf Se BENZAMIDE COMPOUNDS AND THEIR USE AS HERBICIDES
WO2019122345A1 (en) 2017-12-22 2019-06-27 Basf Se Benzamide compounds and their use as herbicides
WO2019162309A1 (en) 2018-02-21 2019-08-29 Basf Se Benzamide compounds and their use as herbicides
WO2019162308A1 (en) 2018-02-21 2019-08-29 Basf Se Benzamide compounds and their use as herbicides

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3625977A (en) 1968-10-04 1971-12-07 Eastman Kodak Co 2-acetal-7-ketal-5-norbornene and 2-acetal-7-ketalnorbornane compounds
US4643757A (en) * 1985-05-20 1987-02-17 Nissan Chemical Industries, Ltd. Herbicidal 4-benzoyl-1-methyl-5-hydroxypyrazoles
US4966998A (en) 1985-03-07 1990-10-30 Ici Americas Inc. Trisubstituted benzoic acid intermediates
WO1996026206A1 (en) * 1995-02-24 1996-08-29 Basf Aktiengesellschaft Pyrazol-4-yl-benzoyl derivatives and their use as herbicides
US5834402A (en) * 1995-02-24 1998-11-10 Basf Aktiengesellschaft Isoxazolylbenzoyl derivatives
US5948917A (en) * 1996-03-26 1999-09-07 Nippon Soda Co., Ltd. 3-(isoxazol-5-yl)-substituted benzoic acid derivative and method for production thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4986845A (en) * 1988-07-15 1991-01-22 Nissan Chemical Industries Ltd. Pyrazole derivatives and herbicides containing them

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3625977A (en) 1968-10-04 1971-12-07 Eastman Kodak Co 2-acetal-7-ketal-5-norbornene and 2-acetal-7-ketalnorbornane compounds
US4966998A (en) 1985-03-07 1990-10-30 Ici Americas Inc. Trisubstituted benzoic acid intermediates
US4643757A (en) * 1985-05-20 1987-02-17 Nissan Chemical Industries, Ltd. Herbicidal 4-benzoyl-1-methyl-5-hydroxypyrazoles
WO1996026206A1 (en) * 1995-02-24 1996-08-29 Basf Aktiengesellschaft Pyrazol-4-yl-benzoyl derivatives and their use as herbicides
US5834402A (en) * 1995-02-24 1998-11-10 Basf Aktiengesellschaft Isoxazolylbenzoyl derivatives
US5948917A (en) * 1996-03-26 1999-09-07 Nippon Soda Co., Ltd. 3-(isoxazol-5-yl)-substituted benzoic acid derivative and method for production thereof

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
Hoch, a study of the acid and bse hydrolysis of bridged ketones, Nov. 1960, J. of Organic Chem., 26, 2066-71.* *
Hoch; A Study of the Acid and Base Hydrolysis of Bridged Ketones Derived from Diels-Alder Adducts of 1,2,3,4-Tetrachloro-5,5-dimethoxycyclopentadiene, Chem. & Ind., 110 (1958), vol. 26 p. 2066-2072.
Mark; Nonstereospecific Diels-Alder Reactions. I. Reaction of Hexachlorocyclopentadiene with 1,2-Disubstituted Ethylenes. J. Org. Chem., vol. 39, No. 21, p. 3179-3181 (1974).
Mitchell et al, an approach utilizing a diels-alder route to 1,2,3-trisubstituted benzenes, Apr. 1985, Tetrahedron, 42, 1741-42.* *
Mitchell et al.; Cis-dimethyldihydropyrene synhesis. An Approach Utilizing a Diels-Alder Route to 1,2,3-Trisubstituted Benzenes.; Tetrahedron, vol. 42, No. 6, p. 1741-1744 (1986).

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9398768B2 (en) 2012-04-27 2016-07-26 Basf Se Substituted N-(tetrazol-5-yl)- and N-(triazol-5-yl)pyridin-3-yl-carboxamide compounds and their use as herbicides
US9926284B2 (en) 2013-07-18 2018-03-27 Basf Se Substituted N-(1,2,4-triazol-3-yl)Arylcarboxamide compounds and their use as herbicides
US9902704B2 (en) 2013-10-10 2018-02-27 Basf Se Substituted N-(tetrazol-5-yl)- and N-(triazol-5-yl)arylcarboxamide compounds and their use as herbicides

Also Published As

Publication number Publication date
EP1097925A1 (en) 2001-05-09
DE69933222D1 (en) 2006-10-26
WO2000003988A1 (en) 2000-01-27
EP1097925B1 (en) 2006-09-13
EP1097925A4 (en) 2001-12-19
DE69933222T2 (en) 2007-01-04

Similar Documents

Publication Publication Date Title
US6756497B1 (en) Benzoic acid derivatives and processes for the preparation thereof
EP1541561B1 (en) Pyrazole derivatives and process for the production thereof
ES2674813T3 (en) Heterocyclic compound containing partially saturated nitrogen
AU2006311797A1 (en) Aminopyrimidines useful as kinase inhibitors
AU2004225977A1 (en) Thiazoles useful as inhibitors of protein kinases
IL147651A (en) Isoxazoline derivative and herbicide containing the same as the active ingredient
EP1467972A1 (en) Indazole compounds useful as protein kinase inhibitors
AU2003212833A1 (en) Indazole compounds useful as protein kinase inhibitors
AU2020407664A1 (en) Fluoroalkyl-oxadiazoles and uses thereof
TW201002715A (en) Heterocyclic compound having inhibitory activity on p13k
EA010628B1 (en) 5-phenylpyrimidines, method for production and use thereof
AU2020343788A1 (en) Piperonylic acid derivative and application thereof
UA73735C2 (en) A method for the preparation of substituted pirimidines (variants)
JP4377992B2 (en) Process for producing aromatic thioether compound
JPWO2019236699A5 (en)
CN115066419A (en) Preparation of substituted 3-aryl-5-trifluoromethyl-1, 2, 4-oxadiazoles
CN115087645A (en) Preparation of substituted 3-aryl-5-trifluoromethyl-1, 2, 4-oxadiazoles
ES2315441T3 (en) PROCESS FOR THE PREPARATION OF CYCLIC DICETONES.
CA3149137A1 (en) Process and intermediates for the preparation of pyroxasulfone
JP4592129B2 (en) Novel benzoic acid derivatives and process for producing the same
EP0934255B1 (en) Production of pyridazine herbicides
JP4804615B2 (en) Method for producing bicycloheptene derivative
JP4600859B2 (en) Heterocyclic substituted thiophenol compounds, intermediates for production thereof, and production methods
WO2001053271A1 (en) Imidazole compounds and their use as adenosine deaminase inhibitors
AU2013201630B2 (en) Aminopyrimidines useful as kinase inhibitors

Legal Events

Date Code Title Description
AS Assignment

Owner name: NIPPON SODA CO., LTD., JAPAN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:NAKAGAWA, YUUKI;YAMAGUCHI, MASAO;ADACHI, HIROYUKI;AND OTHERS;REEL/FRAME:011504/0598;SIGNING DATES FROM 20001212 TO 20001218

FEPP Fee payment procedure

Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

REMI Maintenance fee reminder mailed
LAPS Lapse for failure to pay maintenance fees
STCH Information on status: patent discontinuation

Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362

FP Lapsed due to failure to pay maintenance fee

Effective date: 20080629